Search Results - S Oudard

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    An Analysis Of Cd-ROM as a Long Term Archiving Solution by Denis Oudard

    Published in IASSIST Quarterly (1992-01-01)
    Get full text
    Article


  2. 2

    Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors by Soumaya Karaki, Marie Anson, Thi Tran, Delphine Giusti, Charlotte Blanc, Stephane Oudard, Eric Tartour

    Published in Vaccines (2016-11-01)
    Get full text
    Article


  3. 3

    Correction to: Pericardial effusion under nivolumab: case-reports and review of the literature by Anastasia Saade, Audrey Mansuet-Lupo, Jennifer Arrondeau, Constance Thibault, Mariana Mirabel, François Goldwasser, Stéphane Oudard, Laurence Weiss

    Published in Journal for ImmunoTherapy of Cancer (2019-12-01)
    Get full text
    Article


  4. 4

    Pericardial effusion under nivolumab: case-reports and review of the literature by Saade Anastasia, Mansuet-Lupo Audrey, Arrondeau Jennifer, Thibault Constance, Mirabel Mariana, Goldwasser François, Oudard Stéphane, Weiss Laurence

    Published in Journal for ImmunoTherapy of Cancer (2019-10-01)
    Get full text
    Article


  5. 5

    Cloud thermodynamic phase inferred from merged POLDER and MODIS data by J. Riedi, B. Marchant, S. Platnick, B. A. Baum, F. Thieuleux, C. Oudard, F. Parol, J.-M. Nicolas, P. Dubuisson

    Published in Atmospheric Chemistry and Physics (2010-12-01)
    Get full text
    Article


  6. 6

    Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors. by Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Eva Erdmann, Gonzague de Pinieux, Florence Cabon, Jean-Pierre Bergerat, Marie-France Poupon, Stéphane Oudard

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  7. 7

    Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma by Ivan Pourmir, Nadine Benhamouda, Thi Tran, Hugo Roux, Joséphine Pineau, Alain Gey, Andyara Munoz, Nesrine Mabrouk, Nicolas Epaillard, Virginie Verkarre, Yann-Alexandre Vano, Eric Tartour, Stéphane Oudard

    Get full text
    Article


  8. 8

    Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma by Xiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, Virginie Verkarre, Cheng-Ming Sun, Wenxuan Cheng, Li Xu, Fangrong Yan, Salma Kotti, Wolf Herman Fridman, Catherine Sautes-Fridman, Stéphane Oudard, Gabriel G. Malouf

    Published in npj Precision Oncology (2025-05-01)
    Get full text
    Article


  9. 9

    Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma by Li Xu, Stephane Oudard, Catherine Sautes-Fridman, Xiaoping Su, Gabriel G. Malouf, Virginie Verkarre, Salma Kotti, Fangrong Yan, Yann-Alexandre Vano, Wolf Herve Fridman, Cheng-Ming Sun, Xiaofan Lu, Wenxuan Cheng

    Published in Journal for ImmunoTherapy of Cancer (2025-01-01)
    Get full text
    Article


  10. 10

    Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) by A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey, A. Simonaggio

    Published in OncoImmunology (2023-12-01)
    Get full text
    Article


  11. 11

    Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients by Soufyan Annakib, Emma Di Méglio, Yona Dibert‐Bekoy, Thierry Chevallier, Guilhem Roubaud, Pierre Fournel, Aline Guillot, Delphine Borchiellini, Damien Pouessel, Elouen Boughalem, Remy Delva, Philippe Barthelemy, Stéphane Oudard, Constance Thibault, Diego Tosi, Nadine Houédé, Frédéric Fiteni

    Published in Cancer Medicine (2025-04-01)
    Get full text
    Article


  12. 12

    Humoral complementomics – exploration of noninvasive complement biomarkers as predictors of renal cancer progression by Margot Revel, Mikel Rezola Artero, Houcine Hamidi, Anne Grunenwald, Loris Blasco, Yann A. Vano, Stephane Marie Oudard, Rafael Sanchez-Salas, Petr Macek, Lara Rodriguez Sanchez, Xavier Cathelineau, Benoit Vedié, Catherine Sautes-Fridman, Wolf Herman Fridman, Lubka T. Roumenina, Marie-Agnes Dragon-Durey

    Published in OncoImmunology (2024-12-01)
    Get full text
    Article


  13. 13

    Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma by Stephane Oudard, Nadine Benhamouda, Bernard Escudier, Patrice Ravel, Thi Tran, Emeline Levionnois, Sylvie Negrier, Philippe Barthelemy, Jean François Berdah, Marine Gross-Goupil, Cora N. Sternberg, Petri Bono, Camillo Porta, Ugo De Giorgi, Omi Parikh, Robert Hawkins, Martin Highley, Jochen Wilke, Thomas Decker, Corinne Tanchot, Alain Gey, Magali Terme, Eric Tartour

    Published in Cells (2021-12-01)
    Get full text
    Article


Search Tools: